Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Cyclerion Therapeutics, Inc. (CYCN) had Return on Tangible Equity of -16.28% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$0.08M |
|
$-1.43M |
|
-- |
|
$0.08M |
|
$1.54M |
|
$-1.46M |
|
$0.03M |
|
$-1.43M |
|
$-1.43M |
|
$-1.43M |
|
$-1.43M |
|
$-1.43M |
|
$-1.43M |
|
$-1.46M |
|
$-1.46M |
|
2.56M |
|
2.56M |
|
$-0.56 |
|
$-0.56 |
|
| Balance Sheet Financials | |
$4.50M |
|
-- |
|
$5.35M |
|
$9.85M |
|
$1.07M |
|
-- |
|
-- |
|
$1.07M |
|
$8.78M |
|
$8.78M |
|
$8.78M |
|
3.06M |
|
| Cash Flow Statement Financials | |
$-0.97M |
|
-- |
|
$1.38M |
|
$3.23M |
|
$3.64M |
|
$0.41M |
|
$0.11M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.21 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-1798.77% |
|
-1798.77% |
|
-- |
|
-1764.20% |
|
-1764.20% |
|
$-0.97M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
0.14 |
|
645.56 |
|
-16.28% |
|
|
Return on Tangible Equity |
-16.28% |
-14.51% |
|
-16.28% |
|
$2.87 |
|
$-0.38 |
|
$-0.38 |
|